Design, synthesis, and biological evaluation of 2-arylamino-4-(piperidin-4-yloxy)pyrimidines as potent EGFRT790M/L858R inhibitors to treat non-small cell lung cancer
Author:
Liangliang Tian,Xing Li,Zhenying Lv,Yin Yang,Luhong Wang,Dawei Xu,Xiaodong Ma,Youjun Xu
Publication:
Bioorganic & Medicinal Chemistry
© 2022 Elsevier Ltd. All rights reserved.